IP Library Granted Patent US 10,131,684
Granted Patent B2
US 10,131,684 · App. 15/262,277 · Granted Nov 20, 2018

Process for the preparation of macrolide antibacterial agents

Inventors: David Eugene Pereira (Apex, NC); Manish K. Patel (Toronto, CA); Keshav Deo (Gujarat, IN)
Assignee: CEMPRA PHARMACEUTICALS, INC.
C07H17/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,131,684
App. No.
15/262,277
Granted
Nov 20, 2018
Kind
B2
Abstract

Described herein are processes for the preparation of compounds of formula (I): and pharmaceutically acceptable salts, solvates, and hydrates thereof.

Claims (47)

1. A process comprising (g) reacting a compound of formula (VI)

with a C-substituted alkyne to obtain a compound of formula (VII)

wherein C is selected from the group consisting of hydrogen, alkyl, heteroalkyl, arylalkyl, heteroarylalkyl, aryl, and heteroaryl, each of which is optionally substituted; and R 1b is a saccharide that includes a 2′-hydroxyl group acylated with R 1a , and R 1a is a sterically hindered acyl group; or a salt thereof, wherein

A is CH 2 , C(O), C(O)O, C(O)NH, S(O) 2 , S(O) 2 NH, C(O)NHS(O) 2 ;

B is (CH 2 ) n where n is an integer ranging from 0-10, or B is an unsaturated carbon chain of 2-10 carbons;

V is C(O), C(═NR 11 ), CH(NR 12 R 13 ), or N(R 14 )CH 2 ; where R 11 is hydroxy or alkoxy, each of R 12 and R 13 is independently hydrogen, hydroxy, alkyl, arylalkyl, alkylaryl, alkoxy, heteroalkyl, aryl, heteroaryl, heteroarylalkyl; dimethylaminoalkyl, acyl, sulfonyl, ureyl, and carbamoyl; R 14 is hydrogen, hydroxy, alkyl, arylalkyl, alkylaryl, alkoxy, heteroalkyl, aryl, heteroaryl, heteroarylalkyl, dimethylaminoalkyl, acyl, sulfonyl, ureyl, or carbamoyl;

W is hydrogen, F, Cl, Br, I, or OH; and

X is hydrogen; and Y is OR 7 ; where R 7 is hydrogen, a monosaccharide, a disaccharide, alkyl, aryl, heteroaryl, acyl, or C(O)NR 8 R 9 , where each of R 8 and R 9 is independently hydrogen, hydroxy, alkyl, arylalkyl, alkylaryl, heteroalkyl, aryl, heteroaryl, heteroarylalkyl, alkoxy, dimethylaminoalkyl, acyl, sulfonyl, ureyl, or carbamoyl; or X and Y are taken together with the attached carbon to form C═O.

2. The process of claim 1 further comprising (h) contacting the compound of formula (VII) with a composition comprising an alcohol to prepare a compound of formula (I)

or a salt, solvate, or hydrate thereof; wherein

C is selected from the group consisting of hydrogen, alkyl, arylalkyl, heteroalkyl, aryl, heteroaryl, and heteroarylalkyl, each of which is optionally substituted; and

R 1 is a saccharide that includes a 2′-hydroxy group.

3. The process of claim 1 wherein A-B is alkylene.

4. The process claim 1 wherein A-B is (CH 2 ) 4 .

5. The process of claim 1 wherein W is F.

6. The process of claim 1 wherein C is optionally substituted aryl or optionally substituted heteroaryl.

7. The process of claim 1 wherein C is alkylaryl, aminoaryl, or alkylaminoaryl.

8. The process of claim 1 wherein C is alkylphenyl, aminophenyl, or alkylaminophenyl.

9. The process of claim 1 wherein C is aminophenyl.

10. The process of claim 1 wherein C is 3-aminophenyl.

11. The process of claim 1 wherein the compound of formula (VI) is

wherein A-B is (CH 2 ) 4 .

12. The process of claim 1 wherein the compound of formula (VI) is

wherein A-B is (CH 2 ) 4 .

13. The process of claim 1 wherein the compound of formula (VII) is

wherein A-B is (CH 2 ) 4 .

14. The process of claim 2 wherein the compound of formula (I) is

wherein A-B is (CH 2 ) 4 .

15. A compound of the formula

wherein A is CH 2 and B is (CH 2 ) 3 ;

W is hydrogen or F; and

R 1a is optionally substituted benzoyl.

16. The compound of claim 15 wherein W is hydrogen.

17. The compound of claim 15 wherein W is F.

18. The compound of claim 15 where R 1a is benzoyl.

19. A composition comprising a compound of the formula

in greater than about 98%; wherein

A is CH 2 and B is (CH 2 ) 3 .

20. The composition of claim 19 comprising the compound in greater than about 99%.

21. A composition comprising a compound of the formula

wherein

A is CH 2 and B is (CH 2 ) 3 and optionally a pharmaceutically acceptable carrier, wherein the composition comprises less than about 1.0% by weight of 3-aminophenylethyne compared to the compound.

22. The composition of claim 21 , wherein the composition comprises less than about 0.1% by weight of the 3-aminophenylethyne compared to the compound.

23. The composition of claim 21 , wherein the composition is substantially free of the 3-aminophenylethyne.

24. The process of claim 1 where R 1a is optionally substituted benzoyl.

25. The composition of claim 21 , wherein the composition comprises less than about 0.5% by weight of the 3-aminophenylethyne compared to the compound.

26. The composition of claim 21 , wherein the composition comprises less than about 0.15% by weight of the 3-aminophenylethyne compared to the compound.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2019
From: CEMPRA PHARMACEUTICALS, INC.
To: TETARD, INC.
Reel/Frame 050056/0731 →
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2019
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: CEMPRA PHARMACEUTICALS, INC.
Reel/Frame 049363/0706 →
SECURITY INTEREST Recorded Jan 8, 2018
From: MELINTA THERAPEUTICS, INC.; REMPEX PHARMACEUTICALS, INC.; CEMPRA PHARMACEUTICALS, INC.; CEM-102 PHARMACEUTICALS, INC.
To: CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT
Reel/Frame 045019/0552 →
Continuity (3)
Continuation 12739652
Provisional Application 60982446 · Oct 25, 2007
Related Publication 20170096445A1 · Apr 6, 2017